|
|
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa |
| 1UG1EY033286-01 |
|
NEI |
2022 |
|
|
Computing Core |
| 5P30EY001319-48 |
|
NEI |
2022 |
|
|
Short Term Training in Health Professional Schools |
| 5T35EY007088-37 |
|
NEI |
2022 |
|
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Clinical Center |
| 5UG1EY023204-09 |
|
NEI |
2022 |
|
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Data Coordinating Center |
| 5UG1EY023206-09 |
|
NEI |
2022 |
|
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control |
| 5UG1EY023208-09 |
|
NEI |
2022 |
|
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Clinical Center |
| 5UG1EY023210-09 |
|
NEI |
2022 |
|
|
Spectacle Prescribing in Early Childhood (SPEC) |
| 5UG1EY029657-04 |
|
NEI |
2022 |
|
|
Implementing Integrative HIV-Serious Mental Illness Case Management to Reduce HIV-related Health Disparities |
| 3P30MH043520-34S1 |
|
NIMH |
2022 |
|
|
Project 3 Arlotta |
| 5P50MH094271-10 |
|
NIMH |
2022 |